JESSICA SHARP: Open Payments
NPI 1629164280 · WEST MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,709 in 90 payments from 22 companies in 2025. Trend: 2023 $2,074 · 2024 $1,529 · 2025 $1,709
Food & beverage: $1,709
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $402 |
| ABBVIE INC. | 13 | $207 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $138 |
| PFIZER INC. | 6 | $117 |
| Novo Nordisk Inc | 6 | $117 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $102 |
| Abbott Laboratories | 5 | $96 |
| Axsome Therapeutics, Inc. | 5 | $95 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $93 |
| Lilly USA, LLC | 3 | $64 |
Products named: FARXIGA, TRINTELLIX, JARDIANCE, QULIPTA, CAPLYTA, FREESTYLE LIBRE 3, NURTEC ODT, Auvelity.
Industry payments across LA — which companies pay providers there.
